COVID-19 associated liver injury: A general review with special consideration of pregnancy and obstetric outcomes

World J Gastroenterol. 2022 Nov 14;28(42):6017-6033. doi: 10.3748/wjg.v28.i42.6017.

Abstract

Liver injury is an increasingly recognized extra-pulmonary manifestation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Coronavirus disease 2019 (COVID-19) associated liver injury (COVALI) is a clinical syndrome encompassing all patients with biochemical liver injury identified in the setting of SARS-CoV-2 infection. Despite profound clinical implications, its pathophysiology is poorly understood. Unfortunately, most information on COVALI is derived from the general population and may not be applicable to individuals under-represented in research, including pregnant individuals. This manuscript reviews: Clinical features of COVALI, leading theories of COVALI, and existing literature on COVALI during pregnancy, a topic not widely explored in the literature. Ultimately, we synthesized data from the general and perinatal populations that demonstrates COVALI to be a hepatocellular transaminitis that is likely induced by systemic inflammation and that is strongly associated with disease severity and poorer clinical outcome, and offered perspective on approaching transaminitis in the potentially COVID-19 positive patient in the obstetric setting.

Keywords: COVID-19 liver injury; Perinatal liver disease; Pregnancy; Special populations; Systemic inflammation.

Publication types

  • Review

MeSH terms

  • COVID-19* / complications
  • Female
  • Humans
  • Liver
  • Lung
  • Pregnancy
  • SARS-CoV-2